Senate Amendment A03772
S1206B1554A03772 NAD:EJH 06/22/26 #90 A03772AMENDMENTS TO SENATE BILL NO. 1206Sponsor: SENATOR PENNYCUICKPrinter's No. 1554Amend Bill, page 1, lines 1 through 6, by striking out all of said lines and inserting Amending the act of December 14, 1992 (P.L.1116, No.145), entitled "An act providing minimum standards, terms and conditions for the licensing of persons who engage in wholesale distributions in interstate commerce of prescription drugs; and making a repeal," further providing for definitions and for license application.Amend Bill, page 1, lines 9 through 19; page 2, lines 1 through 30; page 3, lines 1 through 11; by striking out all of said lines on said pages and inserting Section 1. The definition of "virtual manufacturer" in section 3 of the act of December 14, 1992 (P.L.1116, No.145), known as the Wholesale Prescription Drug Distributors License Act, added October 16, 2024 (P.L.988, No.101), is amended and the section is amended by adding a definition to read:Section 3. Definitions.The following words and phrases when used in this act shall have the meanings given to them in this section unless the context clearly indicates otherwise:* * *"Temporary license." A license issued by the department to a manufacturer or a virtual manufacturer under section 5(a.2) for a drug or medical device that has not yet received final approval from the United States Food and Drug Administration."Virtual manufacturer." A person with a place of business located in this Commonwealth in the business of manufacturing and distributing a drug or medical device that:[(1) Holds the drug or device approval and label code or is otherwise identified on the product label from the United States Food and Drug Administration.](1) With respect to the drug or medical device:(i) holds the applicable approval, clearance, authorization or labeler code issued by the United States Food and Drug Administration or is otherwise identified 2026/90NAD/SB1206A03772 - 1 -1234567891011121314151617181920212223242526272829303132333435
on labeling approved, cleared or authorized by the United States Food and Drug Administration; or(ii) for purposes of a temporary license, has submitted to the United States Food and Drug Administration and has pending before the United States Food and Drug Administration an application, premarket notification, request or other submission seeking approval, clearance or authorization for the drug or medical device.(2) At no time takes physical possession of any drug or device in this Commonwealth.* * *Section 2. Section 5 of the act is amended by adding a subsection to read:Section 5. License application.* * *(a.2) Temporary license.-- (1) If the applicant is a manufacturer of a prescription drug or a virtual manufacturer of a drug or medical device that has not yet received approval from the United States Food and Drug Administration, the department may issue a temporary license if the applicant submits all of the following:(i) Documentation demonstrating that an application for approval has been submitted to the United States Food and Drug Administration, including, where applicable:(A) a new drug application number;(B) an abbreviated new drug application number;(C) a biologics license application number;(D) a unique device identification number;(E) a 510(k) premarket notification; or(F) other documentation acceptable to the department demonstrating active review by the United States Food and Drug Administration.(ii) Documentation identifying any contract manufacturing organization or licensed manufacturing facility involved in the manufacture, packaging, labeling or distribution of the drug or medical device.(iii) Documentation demonstrating compliance with applicable requirements of 21 U.S.C. Ch. 9 Subch. V Pt. H (relating to pharmaceutical distribution supply chain).(2) A temporary license issued under paragraph (1): (i) shall expire one year after issuance unless renewed by the department;(ii) shall automatically expire upon denial, withdrawal or refusal of the applicant's approval application by the United States Food and Drug Administration;(iii) may not authorize commercial distribution of a drug or device unless otherwise permitted under Federal law; and2026/90NAD/SB1206A03772 - 2 -123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051
(iv) does not create a property interest in the temporary license and may be suspended or revoked by the department for failure to maintain compliance with this act or applicable Federal law.(3) An applicant issued a temporary license under paragraph (1) shall notify the department within five business days of:(i) approval, denial, withdrawal or refusal of an application by the United States Food and Drug Administration; or(ii) any material change to the applicant's manufacturing or distribution arrangements.(4) Issuance of a temporary license or a license under this subsection may not be construed as approval, endorsement or authorization of a drug or medical device by the Commonwealth.(5) The department may promulgate regulations and develop monitoring, reporting and enforcement procedures necessary to implement this subsection.(6) Upon satisfactory proof provided by the temporary licensee to the department that all conditions for licensure have been met, the department shall convert the temporary license into a license within 30 days.(7) The department may not renew a temporary license more than once for the same applicant.* * *Section 3. This act shall take effect in 60 days.2026/90NAD/SB1206A03772 - 3 -123456789101112131415161718192021222324252627
Official text from the Pennsylvania Legislature. Formatting has been adapted for reading on Ratifi.